Stay updated on Nivolumab Combinations in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in Urothelial Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added a 2025 publication by Tomita et al. on nivolumab plus gemcitabine-cisplatin in urothelial carcinoma. Removed the earlier ahead-of-print citation and updated the study record to Revision v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-28T15:19:52.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The Publications section text now states that publications are automatically filled from PubMed and may not be about the study, and the revision label updated to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-21T12:55:43.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Removed a site-wide government funding status notice at the top of the page; the rest of the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-14T06:47:11.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page shows additions of new update dates (2025-10-24, 2026-02-19, 2025-10-08, 2025-10) and deletions of past update dates (2025-09-18, 2025-11-24, 2025-08-28, 2025-08). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-31T00:42:56.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page updates to version v3.2.0, adds the NIH/operating-status notice and a new research citation, and removes the previous v3.0.2 release tag.
    Difference
    2%
    Check dated 2025-10-02T08:15:19.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page now emphasizes detailed survival and progression metrics for multiple subgroups (cisplatin-eligible/ineligible, PD-L1 status) with updated results dates and locations; older, broader endpoints and some locations have been removed.
    Difference
    67%
    Check dated 2025-09-25T02:44:19.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.